Proteomic Characterization of Cerebrospinal Fluid from Ataxia-Telangiectasia (A-T) Patients Using a LC/MS-Based Label-Free Protein Quantification Technology

<table>Pathway analysis linking five A-T biomarker candidates and ATM. Pathway studio was used to link the A-T biomarker candidates with ATM. Direct interactions are represented by solid lines, whereas indirect interactions are shown in dashed lines.</table>

International Journal of Proteomics

fig2

Figure 2

Figure 2: Proteomic Characterization of Cerebrospinal Fluid from Ataxia-Telangiectasia (A-T) Patients Using a LC/MS-Based Label-Free Protein Quantification Technology 

Figure 2 | Proteomic Characterization of Cerebrospinal Fluid from Ataxia-Telangiectasia (A-T) Patients Using a LC/MS-Based Label-Free Protein Quantification Technology 